Every recall we track for ProRx LLC — 14 in all — plus the complaints and injury reports the public filed about them.
ProRx recalls Semaglutide injections due to lack of sterility assurance. Affected units have NDC 84139-225-02 and lot PRORX052125-4. No remedy specified in recall notice.
ProRx recalls Semag: 12.5/5mL (2.5 mg/mL) multidose vials due to lack of sterility assurance. Affected units have NDC 84139-225-09 and lot number Prorx04282025-3. Stop using immediately.
ProRx recalls 27mg/3mL Tirzepatide injection vials due to lack of sterility assurance. This could lead to infections if used improperly. Affected vials have NDC 84139-209-03 and lot PRORX08062025-3.
ProRx recalls Semaglutide injections with potential lack of sterility assurance. Affected lots from May 2025 production. Consumers should contact ProRx for details.
ProRx recalls Semag: 2.5mg/1mL injections due to lack of sterility assurance. Affected units may cause infection if used. Return to pharmacy for replacement.
ProRx recalls Semaglutide 6mg/2.4mL injections due to lack of sterility assurance. Affected lots from June 2024 production; stop using immediately if you have this medication.
ProRx recalls Semaglutide injections with potential contamination risk. Affected lots have specific batch numbers and expiration dates. Consumers should contact ProRx for details.
ProRx recalls compounded SEMAGLUTIDE 10mg/4mL vials due to lack of sterility assurance. Affected units have NDC 84139-225-04 and were compounded by ProRx in Exton, PA. No remedy specified in recall notice.
ProRx recalls TIRZEPATIDE 60mg/3mL vials due to lack of sterility assurance. Affected vials have specific lot numbers and expiration dates. Consumers should contact ProRx for details.
ProRx recalls SEMAGLUTIDE 5mg/2mL compounded vials due to lack of sterility assurance. Affected vials have specific lot numbers and expiration dates. Consumers should contact ProRx for details.
ProRx recalls Semaglutide/Cyanocobalamin injection vials with potential contamination. Affected vials have NDC 84139-225-02 and Lot # ProRx031924-1. Consumers should contact ProRx for details.
ProRx recalls compounded Tirzepatide injections due to lack of sterility assurance. Affected vials may cause infections if used. Contact ProRx for details.